Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

36.4%

4 terminated/withdrawn out of 11 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

10(90.9%)

Phase 4

1(9.1%)

11Total

N/A(10)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT02982226Not ApplicableUnknown

ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis

Role: lead

NCT03036878Not ApplicableTerminated

ReNu™ Marrow Stimulation Augmentation

Role: lead

NCT02318511Not ApplicableCompleted

An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis

Role: lead

NCT02023372Not ApplicableCompleted

Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine

Role: lead

NCT02837484Not ApplicableUnknown

NuTech Affinity™ for the Treatment of Chondral Defects

Role: lead

NCT02381067Not ApplicableTerminated

A Prospective Study of NuCel® in Cervical Spine Fusion

Role: lead

NCT03828916Not ApplicableUnknown

NuShield in Surgical Peroneal Tendon Repair

Role: lead

NCT03063099Not ApplicableCompleted

ReNu™ Injection to Treat Hip Osteoarthritis Study

Role: lead

NCT02461641Not ApplicableCompleted

NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers

Role: lead

NCT02070484Not ApplicableTerminated

Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease

Role: collaborator

NCT02314416Phase 4Withdrawn

Stem Cells In Wound Healing With Collagen Matrix as a Carrier

Role: collaborator

All 11 trials loaded